Is Novo Nordisk the Best Healthcare Stock for You?

Novo Nordisk (NVO 0.27%), the Danish company behind popular diabetes drug Ozempic and anti-obesity medication Wegovy, has become one of the most valuable businesses in the world. Worth approximately $580 billion already, the company has achieved considerable gains for its shareholders. In five years, the stock has risen by 400%.What's encouraging for investors is that there are still multiple growth catalysts that may push the stock's value up even higher in the. The growth story is by no means over for Nov ...